{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:36:15Z","timestamp":1783632975252,"version":"3.55.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ando.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T14:43:27Z","timestamp":1429627407000},"page":"169-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Parathyroid carcinoma: Challenges in diagnosis and treatment"],"prefix":"10.1016","volume":"76","author":[{"given":"Daniela","family":"Betea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia","family":"Potorac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2015.03.003_bib0500","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","article-title":"Two hundred eighty-six cases of parathyroid carcinoma treated in the US between 1985-1995","volume":"86","author":"Hundahl","year":"1999","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ando.2015.03.003_bib0505","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/(SICI)1098-2388(199703\/04)13:2<134::AID-SSU9>3.0.CO;2-A","article-title":"Functioning parathyroid carcinoma: clinicopathologic features and rational treatment","volume":"13","author":"Obara","year":"1997","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0510","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0960-7404(99)00037-7","article-title":"Parathyroid cancer: biology and management","volume":"8","author":"Koea","year":"1999","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0515","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","article-title":"Trends in the incidence and treatment of parathyroid cancer in the United States","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2015.03.003_bib0520","first-page":"334","article-title":"Parastruma maligna aberrata","volume":"100","author":"De Quervain","year":"1909","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ando.2015.03.003_bib0525","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","article-title":"Parathyroid carcinoma","volume":"86","author":"Shane","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0530","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","article-title":"A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003","volume":"132","author":"Ruda","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ando.2015.03.003_bib0535","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1245\/s10434-010-1003-6","article-title":"Clinical presentation, staging and long-term evolution of parathyroid cancer","volume":"17","author":"Talat","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0540","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1245\/s10434-014-3530-z","article-title":"Oncologic resection achieving r0 margins improves disease-free survival in parathyroid cancer","volume":"21","author":"Schulte","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0545","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0550","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00005792-199207000-00002","article-title":"Parathyroid carcinoma: clinical and pathologic features in 43 patients","volume":"71","author":"Wynne","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ando.2015.03.003_bib0555","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.4081\/rt.2013.e12","article-title":"Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring?","volume":"5","author":"Allen","year":"2013","journal-title":"Rare Tumor"},{"key":"10.1016\/j.ando.2015.03.003_bib0560","first-page":"254","article-title":"Dose-response relationships for radiation-induced hyperparathyroidism","volume":"80","author":"Schneider","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0565","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1667\/0033-7587(2002)158[0418:DRRFPA]2.0.CO;2","article-title":"Dose-response relationship for parathyroid adenoma after exposure to ionizing radiation in infancy","volume":"158","author":"Holmberg","year":"2002","journal-title":"Radiat Res"},{"key":"10.1016\/j.ando.2015.03.003_bib0570","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/jcp.38.10.1114","article-title":"Parathyroid carcinoma associated with chronic renal failure and previous radiotherapy to the neck","volume":"38","author":"Ireland","year":"1985","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ando.2015.03.003_bib0575","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/bjs.1800750914","article-title":"Hyperparathyroidism after neck irradiation","volume":"75","author":"Christmas","year":"1988","journal-title":"Br J Surg"},{"key":"10.1016\/j.ando.2015.03.003_bib0580","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.1990.03450050039024","article-title":"A prospective study of hyperparathyroidism in individuals exposed to radiation in childhood","volume":"264","author":"Cohen","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2015.03.003_bib0585","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2265.2002.01616.x","article-title":"Increased incidence of parathyroid adenomas following X-ray treatment of benign diseases in the cervical spine in adult patients","volume":"57","author":"Rasmuson","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.03.003_bib0590","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/jcp.30.10.966","article-title":"Parathyroid carcinoma in familial hyperparathyroidism","volume":"30","author":"Dinnen","year":"1977","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ando.2015.03.003_bib0595","first-page":"1485","article-title":"Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer","volume":"77","author":"Wassif","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","article-title":"Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds","volume":"81","author":"Simonds","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ando.2015.03.003_bib0605","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4065\/77.8.866","article-title":"Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis","volume":"77","author":"Dionisi","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ando.2015.03.003_bib0610","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03347413","article-title":"Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity","volume":"30","author":"Agha","year":"2007","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.ando.2015.03.003_bib0615","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2265.2007.02894.x","article-title":"Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas","volume":"67","author":"Haven","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.03.003_bib0620","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2265.1997.3421147.x","article-title":"Metastatic parathyroid carcinoma in the MEN2A syndrome","volume":"47","author":"Jenkins","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.03.003_bib0625","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.ando.2015.03.003_bib0630","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors","volume":"89","author":"Cetani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0635","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1210\/jc.2005-0717","article-title":"HRPT2 mutational analysis of typical sporadic parathyroid adenomas","volume":"90","author":"Krebs","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0640","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2015.03.003_bib0645","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/j.seminoncol.2010.10.013","article-title":"Parathyroid cancer","volume":"37","author":"Sharretts","year":"2010","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0650","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","article-title":"Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?","volume":"156","author":"Cetani","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.03.003_bib0655","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hed.20049","article-title":"Parathyroid carcinoma: a 22-year experience","volume":"26","author":"Busaidy","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.ando.2015.03.003_bib0660","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3949\/ccjm.60.4.331","article-title":"Parathyroid carcinoma: 50-year experience at The Cleveland Clinic Foundation","volume":"60","author":"Hakaim","year":"1993","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ando.2015.03.003_bib0665","first-page":"649","article-title":"Parathyroid carcinoma versus parathyroid adenoma in patients with profound hypercalcemia","volume":"101","author":"Levin","year":"1987","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2015.03.003_bib0670","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1373\/clinchem.2007.085506","article-title":"An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma","volume":"53","author":"Rubin","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2015.03.003_bib0675","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2008.03408.x","article-title":"High third generation\/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation\/second generation PTH ratio in patients with primary hyperparathyroidism","volume":"70","author":"Caron","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.03.003_bib0680","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/jc.2009-2791","article-title":"The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma","volume":"95","author":"Cavalier","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0685","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1210\/jc.2013-3730","article-title":"The third\/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform","volume":"99","author":"Cavalier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0690","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2015.03.003_bib0695","first-page":"145","article-title":"Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia","volume":"75","author":"Quarles","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0700","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","article-title":"A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure","volume":"84","author":"John","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0705","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00423-008-0385-4","article-title":"Serum 1-84 and 7-84 parathyroid hormone concentrations and bone in patients with primary hyperparathyroidism","volume":"393","author":"Blachowicz","year":"2008","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ando.2015.03.003_bib0710","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2265.2011.04021.x","article-title":"Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation","volume":"74","author":"Caron","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.03.003_bib0715","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00020840-200404000-00007","article-title":"The management of parathyroid carcinoma","volume":"12","author":"Thompson","year":"2004","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ando.2015.03.003_bib0720","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archsurg.136.8.878","article-title":"Localization and reoperation results for persistent and recurrent parathyroid carcinoma","volume":"136","author":"Kebebew","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.ando.2015.03.003_bib0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.otc.2010.08.002","article-title":"Techniques for parathyroid localization with ultrasound","volume":"43","author":"Lee","year":"2010","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.ando.2015.03.003_bib0730","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00330-011-2141-3","article-title":"Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumours larger than 15mm","volume":"21","author":"Sidhu","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ando.2015.03.003_bib0735","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","article-title":"A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism","volume":"19","author":"Cheung","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0740","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5306\/wjco.v2.i10.348","article-title":"FDG-PET\/CT and parathyroid carcinoma: review of literature and illustrative case series","volume":"2","author":"Evangelista","year":"2011","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0745","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1507\/endocrj.48.213","article-title":"Ultrasonographic features of parathyroid carcinoma","volume":"48","author":"Hara","year":"2001","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2015.03.003_bib0750","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1089\/thy.2005.15.744","article-title":"Parathyroid carcinoma: ultrasonographic and histologic features","volume":"15","author":"Tamler","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2015.03.003_bib0755","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.hoc.2012.08.009","article-title":"Parathyroid carcinoma: challenges in diagnosis and treatment","volume":"26","author":"Mohebati","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ando.2015.03.003_bib0760","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijsu.2010.09.003","article-title":"Focus on parathyroid carcinoma","volume":"9","author":"Kassahun","year":"2011","journal-title":"Int J Surg"},{"key":"10.1016\/j.ando.2015.03.003_bib0765","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF03343718","article-title":"Cutaneous spreading of parathyroid carcinoma after fine needle aspiration cytology","volume":"23","author":"Spinelli","year":"2000","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.ando.2015.03.003_bib0770","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00003072-199901000-00005","article-title":"Detection of metastatic parathyroid carcinoma with Tc-99m sestamibi imaging","volume":"24","author":"Al-Sobhi","year":"1999","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ando.2015.03.003_bib0775","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.cco.0000198019.53606.2b","article-title":"Parathyroid carcinoma","volume":"18","author":"Rodgers","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0780","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.crad.2009.12.005","article-title":"Clinical utility of ultrasound and 99mTc sestamibi SPECT\/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism","volume":"65","author":"Patel","year":"2010","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ando.2015.03.003_bib0785","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00423-005-0555-6","article-title":"Results of iterative surgery for persistent and recurrent parathyroid carcinoma","volume":"390","author":"Iacobone","year":"2005","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ando.2015.03.003_bib0790","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12022-008-9050-2","article-title":"Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma","volume":"19","author":"Delellis","year":"2008","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ando.2015.03.003_bib0795","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/jcp.37.12.1370","article-title":"Histological diagnosis of carcinoma of the parathyroid gland","volume":"37","author":"Smith","year":"1984","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ando.2015.03.003_bib0800","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0","article-title":"Parathyroid carcinoma. A study of 70 cases","volume":"31","author":"Schantz","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2015.03.003_bib0805","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00000478-199308000-00007","article-title":"Histopathological variables and DNA cytometry in parathyroid carcinoma","volume":"17","author":"Bondeson","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2015.03.003_bib0810","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0002-9610(84)90110-7","article-title":"Carcinoma of the parathyroid gland: is it overdiagnosed? A report of three cases","volume":"147","author":"McKeown","year":"1984","journal-title":"Am J Surg"},{"key":"10.1016\/j.ando.2015.03.003_bib0815","series-title":"Parathyroid carcinoma. Tumours of endocrine organs","first-page":"128","author":"Bondeson","year":"2004"},{"key":"10.1016\/j.ando.2015.03.003_bib0820","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1245\/s10434-012-2306-6","article-title":"Classification of parathyroid cancer","volume":"19","author":"Schulte","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0825","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cncr.20089","article-title":"Parathyroid carcinoma: evaluation and interdisciplinary management","volume":"100","author":"Clayman","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2015.03.003_bib0830","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","article-title":"Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma","volume":"10","author":"Tan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ando.2015.03.003_bib0835","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","article-title":"Defining a molecular phenotype for benign and malignant parathyroid tumors","volume":"115","author":"Fernandez-Ranvier","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2015.03.003_bib0840","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.surg.2007.09.014","article-title":"Functional parathyroid carcinoma: long-term treatment outcome and risk factor analysis","volume":"142","author":"Iihara","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2015.03.003_bib0845","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","article-title":"CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer","volume":"2","author":"Cetani","year":"2013","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2015.03.003_bib0850","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.surg.2007.12.012","article-title":"Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations","volume":"143","author":"Sarquis","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2015.03.003_bib0855","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<378::AID-CNCR3>3.0.CO;2-F","article-title":"Parathyroid carcinoma: a diagnostic and therapeutic challenge","volume":"86","author":"Shaha","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2015.03.003_bib0860","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrendo.2012.102","article-title":"Diagnosis and management of parathyroid cancer","volume":"8","author":"Schulte","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2015.03.003_bib0865","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clon.2010.04.007","article-title":"Parathyroid carcinoma","volume":"22","author":"Givi","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0870","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hed.21376","article-title":"Parathyroid carcinoma: a review","volume":"33","author":"Owen","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.ando.2015.03.003_bib0875","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11864-001-0028-2","article-title":"Parathyroid carcinoma","volume":"2","author":"Kebebew","year":"2001","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0880","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00000658-196904000-00022","article-title":"Parathyroid carcinoma: a collective review","volume":"169","author":"Holmes","year":"1969","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2015.03.003_bib0885","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1634\/theoncologist.2009-0185","article-title":"Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics","volume":"15","author":"Abdelgadir Adam","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ando.2015.03.003_bib0890","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12672-010-0042-6","article-title":"Challenges and pitfalls in the management of parathyroid carcinoma: 17-year follow-up of a case and review of the literature","volume":"1","author":"Witteveen","year":"2010","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ando.2015.03.003_bib0895","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archinte.1984.00350140229032","article-title":"Successful combination chemotherapy for metastatic parathyroid carcinoma","volume":"144","author":"Bukowski","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2015.03.003_bib0900","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/cncr.11819","article-title":"Parathyroid carcinoma: is there a role for adjuvant radiation therapy?","volume":"98","author":"Munson","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2015.03.003_bib0905","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0360-3016(98)00098-4","article-title":"Parathyroid carcinoma\u2013the Princess Margaret Hospital experience","volume":"41","author":"Chow","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.03.003_bib0910","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","article-title":"Calcimimetics with potent and selective activity on the parathyroid calcium receptor","volume":"95","author":"Nemeth","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2015.03.003_bib0915","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-14-0166","article-title":"Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab","volume":"171","author":"Karuppiah","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.03.003_bib0920","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/jc.2013-3031","article-title":"Denosumab for management of parathyroid carcinoma-mediated hypercalcemia","volume":"99","author":"Vellanki","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0925","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-107-5-683","article-title":"Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma","volume":"107","author":"Warrell","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2015.03.003_bib0930","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1210\/jc.2003-031825","article-title":"The effect of octreotide on parathyroid carcinoma","volume":"89","author":"Denney","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0935","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0940","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.83.4.4726","article-title":"Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent","volume":"83","author":"Collins","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0945","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jvir.2007.12.440","article-title":"Radiofrequency ablation of functioning lung metastases from parathyroid carcinoma","volume":"19","author":"Iguchi","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ando.2015.03.003_bib0950","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00270-009-9730-4","article-title":"A case report of 20 lung radiofrequency ablation sessions for 50 lung metastases from parathyroid carcinoma causing hyperparathyroidism","volume":"33","author":"Tochio","year":"2010","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.ando.2015.03.003_bib0955","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1200\/JCO.2007.15.9038","article-title":"Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization","volume":"26","author":"Artinyan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2015.03.003_bib0960","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(98)06469-1","article-title":"Control of hypercalcaemia of parathyroid carcinoma by immunisation","volume":"353","author":"Bradwell","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2015.03.003_bib0965","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1210\/jc.2003-031911","article-title":"Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma","volume":"89","author":"Betea","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.003_bib0970","series-title":"The Endocrine Society's 84th Annual Meeting","first-page":"93","article-title":"Hypercalcaemia of parathyroid carcinoma controlled by immunotherapy","author":"Mead","year":"2002"},{"key":"10.1016\/j.ando.2015.03.003_bib0975","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1507\/endocrj.K09E-283","article-title":"First Japanese patient treated with parathyroid hormone peptide immunization for refractory hypercalcemia caused by metastatic parathyroid carcinoma","volume":"57","author":"Horie","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2015.03.003_bib0980","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1530\/eje.0.1420300","article-title":"Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells","volume":"142","author":"Schott","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.03.003_bib0985","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1210\/jcem.87.3.8283","article-title":"Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells","volume":"87","author":"Bachleitner-Hofmann","year":"2002","journal-title":"The J Clin Endocrinol Metab"},{"issue":"Suppl. 5","key":"10.1016\/j.ando.2015.03.003_bib0990","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2014.09.004","article-title":"Mechanism of action of immunotherapy","volume":"41","author":"Disis","year":"2014","journal-title":"Semin Oncol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426615000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426615000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:47:44Z","timestamp":1757717264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426615000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0003426615000244"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2015.03.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parathyroid carcinoma: Challenges in diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}